Accede al análisis completo con tu suscripción
Últimos 20 reportes · 10-K · 10-K/A · 10-Q · 8-K · Fuente: SEC EDGAR
Accede al análisis completo con tu suscripción
SEC CIK: 0001757898
STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. We offer our Customers a unique mix of innovative products and services. These include: consumable products, such as detergents, endoscopy accessories, barrier products, instruments and tools; services, including equipment installation and maintenance, microbial reduction of medical devices, instrument and scope repair, laboratory testing, and outsourced reprocessing; capital equipment, such as sterilizers, surgical tables, and automated endoscope reprocessors; and connectivity solutions such as operating room (“OR”) integrati on. We operate and report our financial information in three reportable business segments: Healthcare, Applied Sterilization Technologies ("AST"), and Life Sciences. Previously, we had four reportable business segments; however, as a result of the fiscal 2025 divestiture of our Dental segment, Dental is presented as discontinued operations.
Ver másPrecio actual · USD
$233.78
P/E LTM
29.48
Precio / EPS LTM diluido
ROIC (NOPAT / IC)
9.3%
NOPAT / (Equity + Debt)
Gross Margin
44.4%
Gross profit / Ingresos
R&D / Revenue
1.9%
R&D / Ingresos
ROE (avg equity)
11.7%
Benef. neto / Patrimonio
ROA (avg assets)
7.7%
Benef. neto / Activo total
Operating Margin
18.9%
Op. income / Ingresos
Margen Neto
13.3%
Benef. neto / Ingresos
| Métrica | LTM jun 26 | 2026 | 2025 | 2024 | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium | 🔒Premium |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGRESOS Y MÁRGENES | |||||||||||
| Ingresos Totales | 6.037B | 5.936B | 5.460B | 5.139B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Cost of Revenue | 3.309B | 3.309B | 3.057B | 2.921B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Profit | 2.683B | 2.627B | 2.403B | 2.218B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 44.4% | 44.3% | 44.0% | 43.2% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| I+D Y GASTOS OPERATIVOS | |||||||||||
| R&D | 115.100M | 112.900M | 107.600M | 103.700M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| R&D / Revenue | 1.9% | 1.9% | 2.0% | 2.0% | 🔒 | 🔒 | |||||
| STOCK-BASED COMPENSATION | |||||||||||
| Stock-Based Compensation | 62.600M | 61.700M | 57.400M | 56.500M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| SBC / Revenue | 1.0% | 1.0% | 1.1% | 1.1% | 🔒 | 🔒 | |||||
| RESULTADO NETO | |||||||||||
| Pretax Income | 1.089B | 1.047B | 796.200M | 702.800M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Interest Expense (P&L) | 60.600M | — | — | — | 🔒 | 🔒 | |||||
| INVENTARIO | |||||||||||
| Inventario Neto | 712.100M | 631.800M | 581.300M | 674.535M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| LIQUIDEZ E INVERSIONES | |||||||||||
| Cash & Equivalentes | 482.300M | 439.600M | 171.700M | 207.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Total Liquid Assets | 482.300M | 439.600M | 171.700M | 207.000M | 🔒 | 🔒 | |||||
| BALANCE — ACTIVOS | |||||||||||
| PP&E Neto | 2.172B | 2.161B | 1.956B | 1.765B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Goodwill | 4.189B | 4.195B | 4.096B | 4.071B | 🔒 | 🔒 | |||||
| CAPITAL Y DEUDA | |||||||||||
| Deuda Total | 1.894B | 1.932B | 2.044B | 3.206B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Net Debt | 1.411B | 1.492B | 1.872B | 2.999B | 🔒 | 🔒 | |||||
| FLUJO DE CAJA Y CAPEX | |||||||||||
| Cash Flow Operativo (CFO) | 1.288B | 1.341B | 1.148B | 973.300M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Capex | 362.900M | 369.000M | 370.100M | 360.300M | 🔒 | 🔒 | |||||
| RATIOS | |||||||||||
| ROIC (NOPAT / IC) | 9.3% | 9.3% | 7.3% | 7.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Gross Margin | 44.4% | 44.3% | 44.0% | 43.2% | 🔒 | 🔒 | |||||
Cifras en miles de millones (B) · Fuente: SEC/EDGAR
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| SG&A | 1.424B | 1.408B | 1.334B | 1.252B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Depreciación & Amort. | 490.900M | 486.500M | 476.200M | 565.200M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Income | 1.142B | 1.102B | 866.600M | 836.100M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | 18.9% | 18.6% | 15.9% | 16.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Tax Expense | 280.800M | 262.200M | 184.700M | 149.500M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Beneficio Neto | 805.000M | 782.300M | 614.600M | 378.200M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | 13.3% | 13.2% | 11.3% | 7.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Diluido | 7.93 | 7.93 | 6.20 | 3.81 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| EPS Básico | 7.97 | 7.97 | 6.24 | 3.83 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Intangibles | 1.563B | 1.620B | 1.854B | 2.119B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Activo Total | 10.736B | 10.737B | 10.147B | 11.064B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Pasivo Total | 3.515B | 3.540B | 3.531B | 4.748B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Patrimonio Neto | 7.207B | 7.184B | 6.603B | 6.302B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Invested Capital | 9.100B | 8.881B | 9.078B | 9.332B | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Acciones en Circulación | 97.500M | 97.800M | 98.300M | 98.883M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| Free Cash Flow (FCF) | 925.600M | 972.400M | 778.000M | 613.000M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 15.3% | 16.4% | 14.3% | 11.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| NOPAT | 847.210M | 825.955M | 665.569M | 658.244M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Recompras de acciones | 340.400M | 235.500M | 211.300M | 11.800M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos pagados | 247.000M | 241.800M | 219.900M | 200.600M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Dividendos por acción | 2.52 | 2.46 | 2.23 | 2.03 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Adquisiciones (Business) | 21.100M | 20.100M | 54.100M | 546.300M | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| 🔒 |
| R&D / Revenue | 1.9% | 1.9% | 2.0% | 2.0% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROE (avg equity) | 11.7% | 11.3% | 9.5% | 6.1% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| ROA (avg assets) | 7.7% | 7.5% | 5.8% | 3.5% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Operating Margin | 18.9% | 18.6% | 15.9% | 16.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Margen Neto | 13.3% | 13.2% | 11.3% | 7.4% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| FCF Margin | 15.3% | 16.4% | 14.3% | 11.9% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Effective Tax Rate | 25.8% | 25.0% | 23.2% | 21.3% | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |
| Debt / Equity Ratio | 0.26x | 0.27x | 0.31x | 0.51x | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 | 🔒 |